Zepbound is a prescription medicine used alongside a reduced calorie diet and increased physical activity for certain adults with obesity or overweight and weight related health conditions. Its active ingredient, tirzepatide, works on hormone pathways involved in appetite and food intake. Prescription eligibility depends on individual health factors, medical history, current medications, and treatment goals.
Zepbound contains tirzepatide and is administered as a once weekly injection. It belongs to a group of medicines known as incretin receptor agonists and acts on GIP and GLP 1 receptors. In the United States, it is approved for chronic weight management in adults with obesity or overweight who have at least one weight related condition, when used together with diet and physical activity. It is also approved for moderate to severe obstructive sleep apnea in adults with obesity. A prescription requires an assessment by an appropriate healthcare professional.
Before prescribing Zepbound, a healthcare professional generally considers a person's overall health, weight related conditions, medical history, and other medications. The assessment helps determine whether the potential benefits and risks are appropriate for the individual.
Prescription decisions may involve:
Reviewing body mass index and weight related health conditions.
Discussing previous weight management efforts.
Reviewing current medications and medical history.
Considering a history of gastrointestinal conditions or pancreatitis.
Evaluating possible risks related to other medicines affecting blood sugar or appetite.
Discussing pregnancy considerations because weight loss treatment is generally not appropriate during pregnancy.
Zepbound is not intended for everyone. It carries important warnings and precautions, including a boxed warning concerning thyroid C cell tumors observed in animal studies. It should not be used by people with a personal or family history of medullary thyroid carcinoma or by individuals with Multiple Endocrine Neoplasia syndrome type 2.
Zepbound treatment is usually started at a lower dose and may be increased gradually according to the prescribing healthcare professional's instructions. Gradual dose adjustment can help the body adapt to the medication and may reduce certain gastrointestinal effects.
Important considerations include:
Common side effects can include nausea, diarrhea, vomiting, constipation, abdominal discomfort, and decreased appetite.
Serious adverse reactions can occur and require medical attention.
Zepbound may interact with certain medicines, particularly medications that can lower blood glucose.
People using Zepbound should follow the prescribed dosing schedule rather than changing the dose independently.
Regular follow-up can help healthcare professionals assess response, tolerability, and ongoing treatment needs.
Weight management treatment is generally most effective when medication is combined with appropriate nutrition, physical activity, and long term lifestyle strategies. Individual results can vary, and treatment decisions should be based on personal medical circumstances rather than expected results from other people.
Zepbound prescription options should therefore be discussed with a qualified healthcare professional. Online information can help explain the medicine, but it cannot replace an individualized medical evaluation.